Apr 29, 2021 by Anirudh Shankar2 Undervalued Pharmaceutical Stocks to Buy NowThese two high-dividend stocks might be great additions to your portfolio.
Apr 27, 2021 by Anirudh ShankarDoes This First-in-Class Acquisition Make Amgen a Buy?Amgen just bought Rodeo Therapeutics in a move that bolsters its drug candidate pipeline.
Apr 27, 2021 by Anirudh ShankarThis Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be OverIts vaccine might not have panned out as expected, but Merck has more in the works.
Apr 24, 2021 by Anirudh ShankarDown Nearly 50% From All-Time Highs, Is This Pharma Giant a Good Buy?You might want to consider adding this company to your portfolio.
Apr 23, 2021 by Anirudh Shankar1 Cheap Pharmaceutical Stock to Buy in 2021GlaxoSmithKline presents a great opportunity for investors this year.
Apr 22, 2021 by Anirudh ShankarWhy Bristol Myers Squibb Deserves a Place in Your PortfolioThis undervalued pharmaceutical is a great buy in 2021.
Apr 14, 2021 by Anirudh ShankarFollow Warren Buffett Into These 3 Pharma CompaniesSee why the world's most acclaimed value investor is investing in these three stocks.
Apr 13, 2021 by Anirudh Shankar2 Stocks That Are Perfect to Buy Now and Hold Until RetirementTheir high yields and history of success bode well for the long term.
Apr 5, 2021 by Anirudh ShankarBetter Buy for 2021: Pfizer or Gilead?In a post-pandemic world, one company has the lower valuation and higher dividend yield to be a success.
Apr 5, 2021 by Anirudh ShankarWhy UnitedHealth Group Still Deserves a Place in Your PortfolioMake this one of your great buys in 2021.
Mar 29, 2021 by Anirudh ShankarThis Stalwart's Growth Story Isn't Over YetIt's a big-name pharma with a storied history, but Eli Lilly still has plenty of room left to run.
Mar 18, 2021 by Anirudh ShankarThere's Always Room for This Blue Chip in Your PortfolioThrough good times and bad, Johnson & Johnson has performed.
Mar 13, 2021 by Anirudh ShankarWhy the Growth Isn't Over for This Best-in-Breed Biotech StockIt's not getting much attention lately, but the future for Amgen looks strong.
Mar 5, 2021 by Anirudh ShankarWhy Pfizer Is Still a Top Stock for 2021Adding some of this pharma giant to your portfolio makes sense for the long run.
Feb 26, 2021 by Anirudh ShankarConsider Buying This Blue Chip on the DipHere's how you can take advantage of the latest sell-off in a stalwart pharma stock.
Feb 21, 2021 by Anirudh ShankarIs It Too Late to Buy AbbVie Stock?In a market where many stocks look overvalued, this company has proven that there are still bargains to be found.
